Objective: The aim of this study was to examine the association between body mass index 31 (BMI) and risk of incident hypertension among Japanese men and women who are 32 middle-aged and older. 33 Design: Prospective, population-based cohort study. 34 Subjects: A total of 68 205 non-hypertensive adults (18 336 men and 49 869 women) aged 35 40-79 years who completed health check-ups in the Ibaraki prefecture, Japan, in 1993 were 36 followed-up through 2006. To exclude the impact of BMI change during the follow-up period, 37 a time-dependent covariate Cox proportional hazards model was used to compute the hazard 38 ratios (HRs) of incident hypertension according to BMI categories. Incident hypertension was 39 defined as a systolic blood pressure (BP) of ≥ 140 mmHg, a diastolic BP of ≥ 90 mmHg, 40 and/or hypertensive medication use. 41 Results: A total of 30 982 adults (45.4%) developed hypertension (9 331 men and 21 651 42 women) during a mean of 3.9 years of follow-up. Compared with a BMI of < 19.0, 43 time-dependent covariates adjusted HRs (95% confidence interval [CI]) for hypertension 44 among participants with a BMI of ≥ 25.0 were 1.42 (1.17-1.73) for men aged 40 to 59 years, 45 1.34 (1.19-1.51) for men aged 60 to 79 years, 1.47 (1.33-1.62) for women aged 40 to 59 years 46 and 1.29 (1.18-1.41) for women aged 60 to 79 years. 47 Conclusion: 51 The baseline BMI is associated with future risk for incident hypertension even 48 after accounting for weight change during the follow-up period. Weight loss may be 49 recommended to non-hypertensive obese adults to prevent the development of hypertension. 50 52 Hypertension is a major cause of cardiovascular disease [1]. Currently, approximately 45% of 53 Japanese adults are considered hypertensive [2], defined as systolic blood pressure (SBP) ≥ 54 140 mmHg, diastolic blood pressure (DBP) ≥ 90 mmHg or treatment with an 55
Introduction
Participants were classified into the following 7 categories with regard to their BMI: < 19.0, 128 19. 0-20.9, 21.0-22.9, 23.0-24.9, 25.0-26.9, 27.0-29.9, or ≥ 30 .0 kg/m 2 . Baseline participant 129 characteristics were compared according to BMI categories using chi-squared tests for 130 categorical variables and analysis of variance for continuous variables. Hazard ratios (HRs) 131 with 95% confidence intervals (CIs) for incident hypertension relative to BMI categories 132 were calculated with a reference of < 19.0 kg/m 2 using a Cox proportional hazards regression 133 model [19] . The analyses were stratified by sex and age groups (40-59 and 60-79 years) . 134 Three multivariable-adjusted models were used. In Model 1, covariates included age 135 (years), SBP (mmHg), DBP (mmHg), fasting status (yes or no), total cholesterol level 136 (mmol/L), HDL cholesterol level (mmol/L), log-transformed triglyceride level (mmol/L), 137 lipid medication use (yes or no), blood glucose status (normal: < 6.1 mmol/L during fasting 138 or < 7.8 mmol/L during non-fasting; border: 6.1-7.0 mmol/L during fasting or 7.8-11.1 139 mmol/L during non-fasting; hyperglycemia: ≥ 7.0 mmol/L during fasting or ≥ 11.1 mmol/L 140 during non-fasting), smoking status (never, ex-, current < 20 cigarettes/day, or ≥ 20 141 cigarettes/day), and alcohol intake (non-, sometimes, < 66 g/day, or ≥ 66 g/day). In Model 2, 142 the changes in BMI, total cholesterol level (mmol/L), HDL cholesterol level (mmol/L), and 143 log-transformed triglyceride level (mmol/L) from baseline to the end of follow-up were 144 added as covariates to Model 1. In Model 3, time-dependent variables of BMI and covariates 145 in Model 1 were used with a time-dependent Cox hazard model, which was used for adjusting 146 the change in the variable from the baseline to the final year of follow-up [20] . For the 147 secondary analysis, we excluded 34 190 participants with incomplete data and 16,370 148 participants with a SBP of ≥ 140 mmHg and/or a DBP of ≥ 90 mmHg or antihypertensive 149 medication use at a 5-year follow-up. The remaining 17 645 qualified participants were 150 classified into the following 4 categories with regard to their baseline BMI and BMI 5 years 151 later: (a) BMI of less than 25 kg/m 2 at baseline and BMI of less than 25 kg/m 2 at a 5-year 152 follow-up (-/-); (b) BMI of 25 kg/m 2 or more at baseline and BMI of less than 25 kg/m 2 at a 153 5-year follow-up (+/-); (c) BMI of less than 25 kg/m 2 at baseline and BMI of 25 kg/m 2 or 154 more at a 5-year follow-up (-/+); and (d) BMI of 25 kg/m 2 or more at baseline and BMI of 25 155 kg/m 2 or more at a 5-year follow-up (+/+). We calculated HRs for incident hypertension to 156 consider long-term changes of their weights.
Results

161
Sex-stratified baseline characteristics according to BMI categories are shown in Table 1 . All 162 covariates, except for blood glucose status, diabetic medication use and smoking status in 163 men and lipid medication use in women, were associated with BMI in both sexes. A higher 164 BMI was linked with higher SBP and DBP at baseline in both sexes. 165 Of the 68 205 adults (18 336 men and 49 869 women), 30 982 (45.4%) developed 166 hypertension (9 331 men and 21 651 women) during a mean follow-up of 3.9 years (3.4 years 167 for men and 4.1 years for women). HRs of +/-, -/+, and +/+ were 1.12 (1.03-1.41), 1.69 (1.47-1.94), and 1.67 (1.53-1.82), 190 respectively. 192 To the best of our knowledge, the results of the present large prospective study showed that 193 stable obesity in non-hypertensive individuals was significantly associated with an increased 194 risk of incident hypertension among men and women who are middle-aged and older. 195 Previous studies that examined the relationship between BMI and hypertension reported 196 results consistent with the present study. Many cross-sectional studies showed a 197 dose-dependent relationship between BMI and the prevalence of hypertension in Caucasian 198 [5, 21] and Asian [3, 13, 22] populations. Kawada [3] reported that the odds ratios for 199 hypertension against the lowest quartile of BMI (separated by 20, 25 and 28) were 1.7, 3.6, 200 and 7.2, respectively, with 95% CIs of 1.2-2.3, 2.5-5.2 and 4.7-11.0, respectively, among 201 middle-aged men and women (5 346 men and 11 525 women, aged 40-59). Prospective 202 studies [4, 12, 23] also showed similar results to the present study. The Physicians' Health 203 Study (13 563 healthy and non-hypertensive men in U.S.) [4] showed that the HRs (95% CIs) 204 of developing hypertension for men with a BMI of 22. 4-23.6, 23.7-24.7, 24.8-26.4, and >26.4 205 kg/m 2 were 1.20 (1.09-1.32), 1.31 (1.19-1.44), 1.56 (1.42-1.72), and 1.85 (1.69-2.03), 206 respectively (P for the trend, < 0.001), compared with participants who had the lowest BMI 207 quintile (< 22.4 kg/m 2 ). A cohort study of U.S. female nurses (82 473 women, aged 30-55) 208 [12] showed that the multivariate HRs (95% CIs) of developing hypertension for women with 209 a BMI of 22.0-22.9, 24.0-24.9, 26.0-27.9, and > 31.0 kg/m 2 were 1.57 (1.44-1.72), 2.15 210 (1.97-2.35), 3.33 (3.06-3.62), and 6.31 (5.80-6.87), respectively (P for the trend, < 0.001), 211 compared with women who had the lowest BMI decile (< 20.0 kg/m 2 ), and an increase in 212 BMI of 1 kg/m 2 was associated with a 12 % increased risk for incident hypertension. These 213 results suggested a strong association between higher BMI and increased risk of incident 214 hypertension in men and women. more than 25 kg/m 2 ) on incident hypertension. The HRs of non-obese people at a 5-years 217 follow-up, despite obesity at baseline, was not significant compared with non-obese people at 218 both baseline and at a 5-years follow-up. In contrast, the HRs of obese individuals at a 5-year 219 follow-up, despite non-obesity at baseline, was significantly higher compared with non-obese 220 people at both baseline and at a 5-years follow-up. The effect of change in BMI on blood 221 pressure has already been examined in some studies [12] [13] [14] [15] [16] [17] [18] . A systematic review [24] of 222 lifestyle intervention studies reported differences ranging from -11 to + 4 kg for weight, -7 to 223 + 2.2 mmHg for DBP and -13 to + 6.1 mmHg for SBP. It is suggested that SBP differences 224 were equal to a ratio of 1 kg to every 1 mmHg. These studies suggest the efficacy of weight 225 loss for the hypertensive obese population. The present study further represented the efficacy 226 of weight loss for the non-hypertensive obese population to prevent incident hypertension. 227 Williams [25] examined the relationship between long-term stable individuals' BMI (change 228 less than ± 0.4 kg/m 2 ) and the cumulative incidence of hypertension and showed that the odds 229 ratio of each kg/m 2 increment in baseline BMI was 1.19 (95% CIs: 1.14-1.24) in men and The exact mechanism by which stable adiposity raises BP is uncertain. However, a likely 239 explanation is that obesity-associated hypertension appears to be due to inadequate 240 vasodilatation in the setting of increased blood volume and cardiac output. A defect in control 241 of vascular resistance has been attributed to enhanced activity of the sympathetic nervous 242 system, abnormal rennin-angiotensin-aldosterone relations, and insulin resistance [27] [28] [29] [30] [31] . 243 The peripheral vascular resistance is increased by adipocytokines (e.g., leptin, TNF-α, RBP4) 244 [32] [33] [34] . 245 The study has several strengths. First, the effect of weight change during the follow-up 246 period was taken into account to investigate the association between long-term weight 247 stability and future incident risk for hypertension, while many previous epidemiological 248 studies did not account for these factors. Second, the present study had a large cohort for 249 which gender, age and BMI stratification analysis was possible. In addition, all blood samples 250 in each year were measured by the same device, reagents, and quality control programs [35] . 251 However, there are several limitations. First, the participation rate for the follow-up 252 examinations was approximately 40%, but the mean SBP and DBP did not differ between 253 individuals who were and were not followed up. In this context, the potential selection bias 254 may have been small. Second, the instrument used to measure the blood pressure was We thank all the participants in this study. Total cholesterol, mmol/liter 5.1 (0.9) 5.2 (0.9) 5.3 (0.9) 5.4 (0.9) 5.4 (0.9) 5.5 (0.9) 5.5 (0.9) <.001 • I I R~(9 5""CI~)
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